Maines, E.; Franceschi, R.; Luppi, G.; Marchi, G.; Piccoli, G.; Vitturi, N.; Soffiati, M.; Campomori, A.; Urru, S.A.M.
Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. Metabolites 2025, 15, 427.
https://doi.org/10.3390/metabo15070427
AMA Style
Maines E, Franceschi R, Luppi G, Marchi G, Piccoli G, Vitturi N, Soffiati M, Campomori A, Urru SAM.
Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. Metabolites. 2025; 15(7):427.
https://doi.org/10.3390/metabo15070427
Chicago/Turabian Style
Maines, Evelina, Roberto Franceschi, Giacomo Luppi, Giacomo Marchi, Giovanni Piccoli, Nicola Vitturi, Massimo Soffiati, Annalisa Campomori, and Silvana Anna Maria Urru.
2025. "Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors" Metabolites 15, no. 7: 427.
https://doi.org/10.3390/metabo15070427
APA Style
Maines, E., Franceschi, R., Luppi, G., Marchi, G., Piccoli, G., Vitturi, N., Soffiati, M., Campomori, A., & Urru, S. A. M.
(2025). Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. Metabolites, 15(7), 427.
https://doi.org/10.3390/metabo15070427
